InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: stockorus post# 164576

Monday, 05/10/2021 11:59:08 PM

Monday, May 10, 2021 11:59:08 PM

Post# of 233221

Also, as someone else mentioned, what happened to the 28 CSP patients? Why no mention of this?


38% of critical patients who received leronlimab in the trial passed away within 28 days. If 11 of the 28 original Filipino patients passed away, that is the kind of news that CytoDyn keeps secret. Just like the severe patients in the CD12. Severe patients represent 5/6ths of the trial and we know absolutely nothing about their data.

HGEN has already released a preprint for their trial. HGEN's trial finished a month after leronlimab's CD12 trial. But then again, we are still waiting on the leronlimab's M2M trial data that finished last summer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News